- Home
- ALZN vs ELAB Comparison
ALZN vs ELAB Comparison
Compare ALZN & ELAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- ELAB
- Stock Information
- Founded
- ALZN 2016
- ELAB 2020
- Country
- ALZN United States
- ELAB United States
- Employees
- ALZN N/A
- ELAB N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- ELAB
- Sector
- ALZN Health Care
- ELAB
- Exchange
- ALZN Nasdaq
- ELAB Nasdaq
- Market Cap
- ALZN 6.1M
- ELAB 6.6M
- IPO Year
- ALZN 2021
- ELAB 2023
- Fundamental
- Price
- ALZN $1.00
- ELAB $4.29
- Analyst Decision
- ALZN Strong Buy
- ELAB
- Analyst Count
- ALZN 1
- ELAB 0
- Target Price
- ALZN $20.00
- ELAB N/A
- AVG Volume (30 Days)
- ALZN 210.7K
- ELAB 416.9K
- Earning Date
- ALZN 03-10-2025
- ELAB 05-14-2025
- Dividend Yield
- ALZN N/A
- ELAB N/A
- EPS Growth
- ALZN N/A
- ELAB N/A
- EPS
- ALZN N/A
- ELAB N/A
- Revenue
- ALZN N/A
- ELAB N/A
- Revenue This Year
- ALZN $322.64
- ELAB N/A
- Revenue Next Year
- ALZN N/A
- ELAB N/A
- P/E Ratio
- ALZN N/A
- ELAB N/A
- Revenue Growth
- ALZN N/A
- ELAB N/A
- 52 Week Low
- ALZN $0.64
- ELAB $3.88
- 52 Week High
- ALZN $15.06
- ELAB $1,064.00
- Technical
- Relative Strength Index (RSI)
- ALZN 51.86
- ELAB 34.32
- Support Level
- ALZN $0.95
- ELAB $4.41
- Resistance Level
- ALZN $1.13
- ELAB $5.07
- Average True Range (ATR)
- ALZN 0.09
- ELAB 0.84
- MACD
- ALZN 0.02
- ELAB 0.28
- Stochastic Oscillator
- ALZN 65.13
- ELAB 16.20
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About ELAB Elevai Labs Inc.
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.